Checkpoint Capital as of March 31, 2024
Portfolio Holdings for Checkpoint Capital
Checkpoint Capital holds 17 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rhythm Pharmaceuticals (RYTM) | 23.9 | $36M | 826k | 43.33 | |
| Argenx Se Sponsored Adr (ARGX) | 21.6 | $32M | 82k | 393.72 | |
| Cytokinetics Com New (CYTK) | 8.9 | $13M | 190k | 70.11 | |
| Avadel Pharmaceuticals Sponsored Adr | 7.9 | $12M | 701k | 16.89 | |
| Axsome Therapeutics (AXSM) | 7.1 | $11M | 132k | 79.80 | |
| Mirum Pharmaceuticals (MIRM) | 6.1 | $9.1M | 362k | 25.12 | |
| Protagonist Therapeutics (PTGX) | 5.4 | $8.1M | 280k | 28.93 | |
| Corcept Therapeutics Incorporated (CORT) | 4.6 | $6.9M | 274k | 25.19 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 3.6 | $5.4M | 619k | 8.71 | |
| Phathom Pharmaceuticals (PHAT) | 3.2 | $4.7M | 445k | 10.62 | |
| Atyr Pharma Com New (ATYR) | 1.9 | $2.8M | 1.4M | 1.95 | |
| Verastem Com New (VSTM) | 1.3 | $2.0M | 169k | 11.80 | |
| Gh Research Ordinary Shares (GHRS) | 1.3 | $2.0M | 186k | 10.66 | |
| Trevi Therapeutics (TRVI) | 1.2 | $1.7M | 506k | 3.45 | |
| Applied Therapeutics (APLT) | 1.0 | $1.5M | 220k | 6.80 | |
| Allakos | 0.6 | $968k | 768k | 1.26 | |
| Atara Biotherapeutics | 0.4 | $620k | 893k | 0.69 |
